Vanguard Group Inc Daxor Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Daxor Corp stock. As of the latest transaction made, Vanguard Group Inc holds 49,028 shares of DXR stock, worth $622,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,028
Previous 49,028
-0.0%
Holding current value
$622,655
Previous $398,000
20.35%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DXR
# of Institutions
8Shares Held
99.7KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny28KShares$355,8660.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL15.9KShares$202,1070.08% of portfolio
-
Morgan Stanley New York, NY3.56KShares$45,1480.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$39,7250.0% of portfolio
-
Jpmorgan Chase & CO New York, NY4Shares$500.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $51.3M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...